Acromegaly screening: Difference between revisions

	Acromegaly Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Acromegaly from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Radiation Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Acromegaly screening On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Acromegaly screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Acromegaly screening
CDC on Acromegaly screening
Acromegaly screening in the news
Blogs on Acromegaly screening
Directions to Hospitals Treating Acromegaly
Risk calculators and risk factors for Acromegaly screening

VisualWikitext

Latest revision as of 15:59, 26 October 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Overview

There is insufficient evidence to recommend routine screening for acromegaly.

Screening

There is insufficient evidence to recommend routine screening for acromegaly.

References

Template:WH Template:WS

@@ Line 4: / Line 4: @@
 ==Overview==
-According to the endocrine society, screening for acromegaly is recommended among patients with clinical features of acromegaly. These features include enlarged [[hands]] and [[feet]], [[frontal]] protrusion, and [[skin]] thickening. The screening is performed by measurement of the [[IGF-1]].
+There is insufficient evidence to recommend routine screening for acromegaly.
 == Screening ==
-*According to the endocrine society, screening for acromegaly by measurement of IGF-1 is recommended among patients with the clinical features of acromegaly. These features include the following:<ref name="pmid25356808">{{cite journal| author=Katznelson L, Laws ER, Melmed S, Molitch ME, Murad MH, Utz A et al.| title=Acromegaly: an endocrine society clinical practice guideline. | journal=J Clin Endocrinol Metab | year= 2014 | volume= 99 | issue= 11 | pages= 3933-51 | pmid=25356808 | doi=10.1210/jc.2014-2700 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25356808  }} </ref>
+There is insufficient evidence to recommend routine screening for acromegaly.
-**Enlarged [[hands]] and [[feet]]
-**Change in the [[facial]] features
-**[[Headache]]
-**Increase [[sweating]]
-**[[Paraesthesia]]
-**[[Skin]] thickening
-**Protrusion of the lower [[jaw]]
-*Screening also is recommended in patients with associated conditions of acromegaly. Acromegaly is associated with different comorbidities so that screening is important in patients with these comorbidities which include:
-**[[Diabetes mellitus|Diabetes Mellitus]]
-**[[Carpal tunnel syndrome]]
-**[[Arthritis]]
-**[[Sleep apnea]]
-**[[Hypertension]]
 ==References==

Acromegaly screening: Difference between revisions

Latest revision as of 15:59, 26 October 2017

Overview

Screening

References

Navigation menu